TOBRADEX Safety Questions, TOBRADEX Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about TOBRADEX. Our extensive database of TOBRADEX adverse events and TOBRADEX warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about TOBRADEX
TOBRADEX Safety Reports
Total TOBRADEX reports: 7.TOBRADEX FDA safety alerts: No.
Reported hospitalizations: 2.
Take TOBRADEX Side Effects Survey or Share Your TOBRADEX Story. TOBRADEX Usage.
Consumer or non-health professional from ITALY reported TOBRADEX problem on Dec 13, 2006. Female patient, 42 years of age, was diagnosed with conjunctivitis and was treated with TOBRADEX. After drug was administered, patient experienced the following problems/side effects: conjunctival haemorrhage, periorbital haematoma, periorbital oedema. TOBRADEX dosage: unknown. During the same period patient was treated with OFTAQUIX. Patient recovered.
TOBRADEX problem was reported by a Consumer or non-health professional from FRANCE on Mar 22, 2007. Female patient, 71 years of age, was treated with TOBRADEX. After drug was administered, patient experienced the following problems/side effects: granulocytopenia, thrombocytopenia. TOBRADEX dosage: unknown. During the same period patient was treated with LEXOMIL, CITALOPRAM HYDROBROMIDE, ENBREL, COSOPT, BISOPROLOL FUMARATE, ATARAX, PREDNISONE, FOSAMAX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TOBRADEX problem on May 04, 2007. Female patient, 71 years of age, was treated with TOBRADEX. After drug was administered, patient experienced the following problems/side effects: eosinophilia, granulocytes maturation arrest, granulocytopenia, thrombocytopenia. TOBRADEX dosage: unknown. During the same period patient was treated with LEXOMIL, CITALOPRAM HYDROBROMIDE, ENBREL, COSOPT, BISOPROLOL FUMARATE, ATARAX, PREDNISONE, FOSAMAX. Patient was hospitalized. Patient recovered.
TOBRADEX problem was reported by a Pharmacist from UNITED STATES on Oct 24, 2006. Male patient, 58 years of age, weighting 170.0 lb, was treated with TOBRADEX. After drug was administered, patient experienced the following problems/side effects: dry mouth, dysgeusia. TOBRADEX dosage: unknown. Patient recovered.
Consumer or non-health professional from ITALY reported TOBRADEX problem on Dec 11, 2006. Male patient, 48 years of age, was diagnosed with conjunctivitis and was treated with TOBRADEX. After drug was administered, patient experienced the following problems/side effects: conjunctival haemorrhage, eyelid oedema, periorbital haematoma. TOBRADEX dosage: unknown. During the same period patient was treated with DICLOTEARS. Patient recovered.
TOBRADEX problem was reported by a Consumer or non-health professional from UNITED STATES on July 30, 2007. Female patient, 36 years of age, weighting 140.0 lb, was diagnosed with conjunctivitis and was treated with TOBRADEX. After drug was administered, patient experienced the following problems/side effects: epistaxis, eye infection, keratoconjunctivitis sicca, unevaluable event, vitreous floaters. TOBRADEX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported TOBRADEX problem on Sept 04, 2007. Female patient, 59 years of age, weighting 215.0 lb, was diagnosed with eye infection and was treated with TOBRADEX. After drug was administered, patient experienced the following problems/side effects: diplopia, impaired driving ability, vision blurred. TOBRADEX dosage: unknown. Patient recovered.